300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Facebook
Blockchain
B2B
Social Network
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Construction
Automotive
Legal
Sports
eSports
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Theatre
Recruiting
Crowdfunding
Web3
Medical
Fashion
Social
Venture Capital
Infrastructure
Beauty
Celebrity
Cannabis
Climate
LGBT
Publishing
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Music
Real Estate
Art
Sporting Goods
Digital Media
Finance
Manufacturing
FinTech
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Biotech
Proptech
Sustainability
Hardware
Transportation
Impact
Enterprise
Community
Media (Entertainment)
Any country
Burkina Faso
South Korea
Africa
LATAM
Singapore
Brazil
Saudi Arabia
Oceania
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Tunisia
Russian Federation
Togo
Tajikistan
Zimbabwe
Nigeria
Guinea
Nepal
Iran
Kyrgyzstan
Isle of Man
Pakistan
Romania
Colombia
Oman
Cameroon
Australia
New Zealand
China
Sri Lanka
Armenia
Costa Rica
Switzerland
Czech Republic
Cayman Islands
Kenya
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Malawi
Moldova
Seychelles
United Kingdom
Botswana
Japan
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Poland
Philippines
Portugal
Sierra Leone
Rwanda
El Salvador
Senegal
Thailand
Uruguay
Tanzania
India
Germany
Canada
United States
Ireland
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Europe
Angola
Argentina
Bangladesh
Barbados
Belgium
Ethiopia
Jordan
Austria
Azerbaijan
Ecuador
Bulgaria
Bahrain
Bahamas
Faroe Islands
Jersey
Estonia
Bolivia
Algeria
Belize
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 10 Biotech Startup Investors in Latvia (July 2026)

The most active venture capital funds and angel investors investing in Latvia Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Latvia Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Imprimatur Capital Fund Management
VC Fund
6 Latvia, United States, United Kingdom Seed, Debt Financing Software, Information Technology, Apps $63k–$549k
Inovo.vc
VC Fund
2 Poland, United States, United Kingdom Seed, Pre-Seed, Series A Software, Artificial Intelligence, Information Technology $300k–$23M
FlyCap
VC Fund
2 Latvia, Estonia, The Netherlands Seed, Debt Financing Health Care, Rental, Medical $55k–$2.9M
SOSV
VC Fund
2 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Abingworth
VC Fund
2 United States, United Kingdom, France Series B, Series A, Series C Biotechnology, Health Care, Pharmaceutical $14M–$120M
Qiming Venture Partners USA
VC Fund
2 United States, Canada, China Series A, Series B, Seed Biotechnology, Health Care, Pharmaceutical $6M–$116M
Surveyor Capital
VC Fund
1 United States, China, Canada Series B, Post-IPO Equity, Series C Biotechnology, Health Care, Therapeutics $41M–$280M
TSVC
VC Fund
1 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$55M
ZGI Capital
VC Fund
1 Latvia, Estonia Seed, Debt Financing Manufacturing, Machinery Manufacturing, Retail $55k–$981k
Alexandria Venture Investments
VC Fund
1 United States, Canada, France Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$150M
Access all 44 investors in Latvia Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Imprimatur Capital Fund Management
VC Fund · Riga, Riga, Latvia · 6 investments in Latvia Biotech startups

Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.

Show more...

Investment focus

  • Industry: Software, Information Technology, Apps
  • Stage:Seed, Debt Financing
  • Geography: Latvia, United States, United Kingdom

Investor stats

  • Total investments: 81
  • Round size: Seed $131k–$549k; Debt Financing $63k–$70k
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2010

Portfolio highlights

  • Axial3D — Leading the way with the latest 3D imaging, models, and devices
  • afriQloud — AfriQloud provides a white-labeled cloud computing solution to telecom operators, internet service providers, system integrators, and managed information technology service providers.
  • Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.
Show all investments...

Inovo.vc
VC Fund · Warsaw, Mazowieckie, Poland · 2 investments in Latvia Biotech startups

VC for the most ambitious founders in CEE

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Poland, United States, United Kingdom

Investor stats

  • Total investments: 94
  • Round size: Seed $300k–$9M; Pre-Seed $620k–$4.5M; Series A $3.4M–$23M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $119M in 2022

Portfolio highlights

  • Booksy — Booksy - book appointments online. Find & book beauty services like hairdressing, manicure, spa or massage. Check prices & reviews!
  • GRAI — GRAI is an AI music research company building the intelligence layer for musical intent — transforming music from passive listening into social participation.
  • Ingenix — Our solution leverages proprietary multimodal AI essential for tackling the complexities of multimodal biological systems.
Show all investments...

FlyCap
VC Fund · Riga, Riga, Latvia · 2 investments in Latvia Biotech startups

FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.

Show more...

Investment focus

  • Industry: Health Care, Rental, Medical
  • Stage:Seed, Debt Financing
  • Geography: Latvia, Estonia, The Netherlands

Investor stats

  • Total investments: 30
  • Round size: Seed $55k–$2.9M; Debt Financing $329k–$2.2M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: May invest from a new fund soon — raised $18M in 2013

Portfolio highlights

  • Mintos — Mintos is a platform that provides retail investors with an accessible way to build wealth through loan-based investments. Through their platform retail investors can invest in a diversified way in income-producing assets to build wealth in the long term. They implement environmental, social, and employee matters, respect for human rights,anti‐corruption, and anti‐bribery matters within their remuneration policy practices and other internal company documents.
  • Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
  • Elmo — In our mobility-focused operations, we wanted to optimize business and decrease environmental impact, so we created remote control technology to deliver cars.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 2 investments in Latvia Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Abingworth
VC Fund · London, England, United Kingdom · 2 investments in Latvia Biotech startups

We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 173
  • Round size: Series A $14M–$115M; Series B $18M–$95M; Series C $20M–$120M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — raised $356M in 2023

Portfolio highlights

  • Attenua — 100% satisfaction guaranteed. Hassle-free shopping. We help you find the right domain name.
  • Iambic — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
  • Addition Therapeutics — Addition Therapeutics focuses on developing RNA-only therapeutics using its proprietary PRINT technology. This approach enables the precise insertion of genetic elements at specific safe harbor sites, aiming to transform the field of genetic medicine. They operate within the biotechnology industry and are backed by venture capital. Their innovativemethods target gene editing and regulation, potentially offering new solutions in the field of genetic therapies.
Show all investments...

Qiming Venture Partners USA
VC Fund · Cambridge, Massachusetts, United States · 2 investments in Latvia Biotech startups

Qiming Venture Partners USA, founded in 2017, is a healthcare venture capital firm and healthcare investor with deep technical expertise that allows them to identify tomorrow's innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.Because of theirproven, hands-on approach to supporting CEOs and scaling operations, its partners are frequently sought after to serve on company boards. They are respected business and thought leaders.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, China

Investor stats

  • Total investments: 39
  • Round size: Seed $6M–$55M; Series A $14M–$92M; Series B $36M–$116M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Dualitas Therapeutics — Dualitas Therapeutics is leading the way in bispecific antibody treatments for inflammatory and immunological (I&I) disorders and other conditions. With a growing collection of innovative cell surface proximity engagers and our in-house DualScreen™ discovery engine, our pipeline
  • Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
  • Rhino Federated Computing
Show all investments...

Surveyor Capital
VC Fund · Chicago, Illinois, United States · 1 investments in Latvia Biotech startups, 14 in the past 12 months

Surveyor Capital is a fundamental equities business. Surveyor’s sector-aligned investment teams aim to generate alpha through a deep understanding of each company’s strategy, management teams, drivers of performance, and cyclical and secular industry trends over the medium and long term.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Post-IPO Equity, Series C
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 165
  • Round size: Series B $57M–$170M; Series C $60M–$200M; Post-IPO Equity $41M–$280M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • Sol-Gel Technologies — Sol-Gel designs and delivers innovative dermatological drugs ranging from completely non-leachable to highly-controlled-release of unique formulations and compounds.
  • Perspective Therapeutics — Perspective Therapeutics is dedicated to finding the best ways to deliver remedies to patients and their medical needs, and they believe in a targeted, individualized approach to cancer treatment. We design treatments that are given exactly where the doctor needs them.
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 1 investments in Latvia Biotech startups

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 263
  • Round size: Seed $500k–$7M; Series A $2.7M–$55M
  • Lead/follow: 7% lead, 93% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Preveta — An intelligent care navigation platform designed for specialty care
  • BloomTech — BloomTech provides online technical coding courses including data science, full-stack web and backend development, and free coding courses.
  • Path — We help you acquire the perfect domain for your site. Affordable payment options. Quick and responsive customer support available.
Show all investments...

ZGI Capital
VC Fund · Riga, Riga, Latvia · 1 investments in Latvia Biotech startups

ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.

Show more...

Investment focus

  • Industry: Manufacturing, Machinery Manufacturing, Retail
  • Stage:Seed, Debt Financing
  • Geography: Latvia, Estonia

Investor stats

  • Total investments: 27
  • Round size: Seed $55k–$896k; Debt Financing $110k–$981k
  • Lead/follow: 89% lead, 11% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • eAgronom — We enable companies to achieve their sustainability goals while supporting farmers in generating additional revenue, improving soil quality, and accessing better financing.
  • RoyaltyRange — RoyaltyRange is a data provider with 4 professional databases covering Royalty rates, Service fees, Loan rates, Companies' financials.
  • Electrify — Electrify manufactures electric buses and minibusses offers charging solutions, and bus infrastructure maintenance.
Show all investments...

Alexandria Venture Investments
VC Fund · Pasadena, California, United States · 1 investments in Latvia Biotech startups

Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, Canada, France

Investor stats

  • Total investments: 264
  • Round size: Seed $2M–$31M; Series A $12M–$101M; Series B $25M–$150M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • miRecule — MiRecule is an early-stage biotechnology company that focuses on developing microRNA-based therapeutics. It features a genomic-based drug development platform that integrates genomic sequencing, expression, and prognostic data from cancer patients. The company was founded in 2016 and headquartered in Gaithersburg, United States.
  • Deep Genomics — Revolutions in AI, biology and automation are enabling a new approach to medicine. Deep Genomics is at the forefront.
  • Vedana Therapeutics — Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for migraine prevention.
Show all investments...

Biotech Investor funding in Latvia at a glance

Stats across 28 deals from 44 investors.

44
investors
in Latvia Biotech startups
28
deals
in Latvia Biotech startups
$532k
median round
in Latvia Biotech startups
39%
lead investors
lead at least one round
29%
Grant
most common funding stage
98/2
VC / Angel
share of investor count

Access all 44 investors in Latvia Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Latvia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 44 investors investing in Latvia Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists